The information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.
SUBJECT TO COMPLETION, DATED FEBRUARY 14, 2023
PROSPECTUS
TeraWulf Inc.
23,392,638 Shares of Common Stock
___________________________
The selling stockholders named in this prospectus (the “Selling Stockholders”) may offer and sell from time to time up to 23,392,638 shares of our common stock, par value $0.001 per share covered by this prospectus, consisting of (i) 7,481,747 shares of common stock, par value $0.001 per share (the “Existing Shares”), (ii) 7,481,747 shares of our common stock, par value $0.001 per share issuable upon exercise of 7,481,747 warrants issued in a private placement transaction which closed on October 6, 2022 (the “October Private Placement Warrant Shares”) issued to certain of the Selling Stockholders (the “October Private Placement Warrants”) pursuant to the October Private Placement Warrant Agreement (as defined herein), (iii) 2,667,678 shares of our common stock, par value $0.001 per share (the “Lender Warrant Shares”) issuable upon exercise of warrants issued to the Company’s lenders (the “Lender Warrants”) pursuant to the Amended and Restated Warrant Agreement (as defined herein), (iv) 4,375,000 shares of our common stock, par value $0.001 per share issuable upon exercise of 5,625,000 warrants issued in a private placement transaction which closed on December 12, 2022 (the “December Private Placement Warrant Shares” and together with the October Private Placement Warrant Shares and the Lender Warrant Shares, the “Warrant Shares”) issued to certain of the Selling Stockholders (the “December Private Placement Warrants” and together with the October Private Placement Warrants and the Lender Warrants, the “Warrants”) pursuant to the December Private Placement Warrant Agreement (as defined herein), and (v) 1,386,466 shares of our common stock, par value $0.001 per share issued in a private placement transaction which closed on February 1, 2023 (the “February Private Placement Shares” and together with the Warrant Shares and the Existing Shares, the “Shares”).
The October Private Placement Warrants entitle the holders thereof to acquire an aggregate of 7,481,747 Warrant Shares. The October Private Placement Warrants have an initial exercise price of $1.93 per share, subject to adjustment in certain circumstances. Holders of the October Private Placement Warrants have the option to exercise on a “cashless basis” by surrendering October Private Placement Warrants to pay the applicable exercise price. The October Private Placement Warrants became exercisable on October 6, 2022 and will expire on October 6, 2027.
The Lender Warrants entitle the holders thereof to acquire an aggregate of 2,667,678 Warrant Shares. The Lender Warrants have an initial exercise price of $0.01 per share, subject to adjustment in certain circumstances. The Lender Warrants became exercisable on September 29, 2022 and will expire on December 31, 2025.
The Company offered 11,250,000 December Private Placement Warrants which entitled the holders thereof to acquire an aggregate of 8,750,000 Warrant Shares. The December Private Placement Warrants have an initial exercise price of $0.40 per share, subject to adjustment in certain circumstances. The December Private Placement Warrants became exercisable on January 16, 2023 and expired on January 31, 2023.5,625,000 of the December Private Placement Warrants were unexercised as of January 31, 2023 and therefore expired. The remaining5,625,000 of such warrants were exercised for 4,375,000 December Private Placement Warrant Shares before January 31, 2023.
We will not receive any proceeds from the sale of the Shares by the Selling Stockholders pursuant to this prospectus. However, we may receive proceeds from any exercise of the Warrants. We have agreed to pay certain registration expenses, other than commissions or discounts of underwriters, broker, dealers or agents. The Selling Stockholders from time to time may offer and sell the Shares held by them directly or through underwriters, broker, dealers or agents on terms to be determined at the time of sale, as described in more detail in this prospectus. Refer to the section titled “Plan of Distribution.”